All In MedTech

Device Trial Radar · NCT07316517

Versius Clinical Study in Robot Assisted Inguinal Hernia Repair Surgery

Prospective Clinical Study to Evaluate the Safety and Efficacy of Versius in Robot-Assisted Inguinal Hernia Repair Surgery

Last checked: Nov 20, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Jul 22, 2026

Primary completion

Nov 2026

Study completion Dec 2026

Sponsor

Lead sponsor
CMR Surgical LtdNot on our public-company list
Sponsor type
Industry
Collaborators
Hospital Universitari de Bellvitge; Niguarda Hospital
First posted
Jan 5, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this clinical trial is to evaluate the safety and efficacy of Versius in Inguinal Hernia repair surgery

Conditions

  • Robotic Assisted Inguinal Hernia Repair

Interventions

  • Versius Surgical SystemDevice

    Modular robotic system intended to assist in the accurate control of its surgical endoscopic instruments across a range of surgical procedures.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Success rateTime frame: Up to completion of surgery

1 more outcomes with a free account

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Division of General Oncologic and Minimally Invasive Surgery, Niguarda Hospital Milan

    Milan, Italy · Recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.